ATC Group: M02AA31 Loxoprofen

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M02AA31 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M02 Topical products for joint and muscular pain
3 M02A Topical products for joint and muscular pain
4 M02AA Antiinflammatory preparations, non-steroids for topical use
5 M02AA31

Active ingredients in M02AA31

Active Ingredient Description
Loxoprofen

Loxoprofen has excellent analgesic, anti-inflammatory and antipyretic properties, with particularly potent pain-relieving activity. This drug is a prodrug which is biotransformed into an active metabolite trans-OH form (SRS coordination) to exert its actions. Inhibition of prostaglandin biosynthesis constitutes the mechanism of action of loxoprofen, the site of action being cyclo-oxygenase.

Medicines in this ATC group

Brazil (BR)

Japan (JP)

Mexico (MX)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.